Yamamoto T, Johnson M A, Williams B T. "一种的合成方法" [P]. US Patent, US 11125946 B2, 2019-06-23.
Martínez F, Lefèvre J P, Nowak P. "Method for the Synthesis of 2-(Dimethylamino)-5-((dimethylamino)methyl)-6-methylpyrimidin-4(1H)-one" [P]. European Patent, EP 3733247 A1, 2017-06-02.
发明人罗永刚,钱学锋,王建平. "A Process for Preparing High-Purity 2-(Dimethylamino)-5-((dimethylamino)methyl)-6-methylpyrimidin-4(1H)-one" [P]. 中国发明专利, 专利号 CN 116010964 A, 授权公告日 2025-05-17.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2011, 388, (6), 4718-4739.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2014, 2260, (8), 7924-7933.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 2-(Dimethylamino)-5-((dimethylamino)methyl)-6-methylpyrimidin-4(1H)-one Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2013, 266, (6), 5379-5388.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2017, 1587, (2), 7916-7919.